TY  - JOUR
AU  - Rojas-Torres, Marta
AU  - Jiménez-Palomares, Margarita
AU  - Martín-Ramírez, Javier
AU  - Beltrán-Camacho, Lucía
AU  - Sánchez-Gomar, Ismael
AU  - Eslava-Alcon, Sara
AU  - Rosal-Vela, Antonio
AU  - Gavaldá, Sandra
AU  - Durán-Ruiz, Mª Carmen
PY  - 2020
DO  - 10.3389/fcell.2020.602837
SN  - 2296-634X
UR  - http://hdl.handle.net/10668/16853
T2  - Frontiers in cell and developmental biology
AB  - Background: Bone Marrow Mononuclear Cells (BM-MNC) constitute a promising alternative for the treatment of Chronic Limb-Threatening ischemia (CLTI), a disease characterized by extensive blockade of peripheral arteries, clinically presenting as...
LA  - en
KW  - BM-MNC
KW  - Chronic limb-threatening ischemia
KW  - angiogenesis
KW  - bio-distribution assay
KW  - critical limb ischemia
KW  - revascularization
KW  - stem cell therapy
TI  - REX-001, a BM-MNC Enriched Solution, Induces Revascularization of Ischemic Tissues in a Murine Model of Chronic Limb-Threatening Ischemia.
TY  - research article
VL  - 8
ER  -